Evidence map›Paper›PMID 35805291›Full record

ArticleInternational journal of environmental research and public health2022

Facilitators and Barriers of Medication Adherence Based on Beliefs of Persons with Bipolar Disorder: A Qualitative Study.

Jose Ángel Alcalá, Andrés Fontalba-Navas, Miguel Company-Morales, Samuel L Romero-Guillena, Teófilo Gutiérrez-Higueras, Luis Gutiérrez-Rojas

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Jose Ángel AlcaláClinical Unit of Mental Health, Reina Sofia University Hospital, 14004 Cordoba, Spain.ORCID 0000-0003-3455-4880
Andrés Fontalba-NavasNorthern Málaga Integrated Healthcare Area, Antequera Hospital, 29200 Antequera, Spain.
Miguel Company-MoralesFaculty of Nursing, Physiotherapy and Medicine, University of Almeria, 04120 Almeria, Spain.ORCID 0000-0002-9124-1883
Samuel L Romero-GuillenaClinical Unit of Mental Health, Virgen Macarena University Hospital, 41009 Seville, Spain.
Teófilo Gutiérrez-HiguerasClinical Unit of Mental Health, Reina Sofia University Hospital, 14004 Cordoba, Spain.
Luis Gutiérrez-RojasDepartment of Psychiatry, School of Medicine, University of Granada, Tower A, Floor 9, 18071 Granada, Spain.ORCID 0000-0003-0082-2189
Andalusian Health Service · ESHospital Universitario Reina Sofía · ESHospital Universitario Virgen Macarena · ESUniversidad de Granada · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the big challenges in treating individuals with bipolar disorder (BD) is nonadherence to medication. This is the principal factor associated with a worse prognosis or outcome of the disease. This study aimed to explore and analyze the individual perceptions that people with BD have about the positive and negative aspects when taking medication. A descriptive and interpretative study was carried out using the qualitative research paradigm with the use of the analytical technique of discourse analysis, extracting the data through the completion of focus groups. Participants' speech was digitally audio-recorded in digital format. In order to complete the codification of the participants' speech content, we relied on the qualitative data analysis (using the QRS NVivo 10 computer software). Thirty-six participants diagnosed with bipolar disorder took part in our study. In the participants' speech concerning the main barriers to pharmacological treatment, three key topics were identified. Perceived facilitators were summarized in four factors. The main facilitators regarding the use of pharmacological treatment in individuals with BD were the ones related with the perceived need for treatment in the acute phase, the recognition of the illness, the shared clinical decision, and the causal biological attribution in the chronic phase. In terms of perceived barriers, social control was identified in both phases, adverse effects in the acute phase, and the absence of effective treatment in the chronic state.

Indexed as

Bipolar DisorderFocus GroupsHumansMedication AdherenceQualitative Researchacceptabilityadherencebipolar disordercore beliefsgroup intervention

Identifiers

PMID35805291
PMCPMC9265403
OpenAlexW4283312509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.